Cite
HARVARD Citation
Chenard-Poirier, M. et al. (n.d.). 1184PA phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chenard-Poirier, M. et al. (n.d.). 1184PA phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors. Annals of oncology. p. . [Online].